
Sign up to save your podcasts
Or
In this episode of Conversations in Lung Cancer Research, A/Prof Mel Moore speaks with Prof Wendy Cooper, a leading pathologist in cancer research. They discuss Wendy's journey into pathology, the evolution of lung cancer diagnostics, the impact of AI and liquid biopsies, and the importance of international collaboration in research. Wendy shares insights on the challenges of equitable access to cancer diagnostics and the pressures faced by pathologists in multidisciplinary meetings. The conversation concludes with advice for junior clinicians on career development and involvement in professional organisations.
(00:00) Introduction and Acknowledgements
(00:36) Introducing Prof Wendy Cooper
(01:32) Wendy's Path to Pathology
(04:42) The Evolution of Lung Cancer Pathology
(08:18) The Role of AI in Pathology
(10:30) Translational Research and International Collaboration
(14:09) Molecular Testing Guidelines in Australia
(18:05) Challenges and Future Directions in Pathology
(26:52) The Impact of Lung Cancer Screening Programs
(29:08) Final Thoughts and Advice
In this episode of Conversations in Lung Cancer Research, A/Prof Mel Moore speaks with Prof Wendy Cooper, a leading pathologist in cancer research. They discuss Wendy's journey into pathology, the evolution of lung cancer diagnostics, the impact of AI and liquid biopsies, and the importance of international collaboration in research. Wendy shares insights on the challenges of equitable access to cancer diagnostics and the pressures faced by pathologists in multidisciplinary meetings. The conversation concludes with advice for junior clinicians on career development and involvement in professional organisations.
(00:00) Introduction and Acknowledgements
(00:36) Introducing Prof Wendy Cooper
(01:32) Wendy's Path to Pathology
(04:42) The Evolution of Lung Cancer Pathology
(08:18) The Role of AI in Pathology
(10:30) Translational Research and International Collaboration
(14:09) Molecular Testing Guidelines in Australia
(18:05) Challenges and Future Directions in Pathology
(26:52) The Impact of Lung Cancer Screening Programs
(29:08) Final Thoughts and Advice
600 Listeners
112 Listeners
1,383 Listeners
306 Listeners
611 Listeners
57 Listeners
4 Listeners
4 Listeners